Dr. Alperen Taş | Cardiology | Best Researcher Award

Ahi Evran University | Turkey

Dr. Alperen Taş is an emerging cardiology researcher whose work centers on acute heart failure, coronary syndromes, inflammatory biomarkers, prognostic scoring systems, and no-reflow phenomena. He focuses on developing and validating clinical biomarkers and risk-prediction models that enhance early diagnosis, guide clinical decisions, and improve mortality prediction in high-risk cardiac patients. His peer-reviewed contributions span key diagnostic tools, including the Scottish Inflammatory Prognostic Score, prognostic nutritional index, QT interval–GRACE score integration, intracoronary ECG, HALP score, Osaka Prognostic Score, and novel biomarkers such as PDGF-BB, chemerin, and derived NLR. His collaborative studies explore infective endocarditis, myocardial infarction, coronary no-reflow, heart failure progression, echocardiographic functional assessment, and medication-related cardiovascular effects. He has shared his findings at national cardiology congresses, advancing scientific dialogue on inflammatory markers and cardiovascular prognostication. With 12 publications, 24 citations, and an h-index of 2, Dr. Alperen Taş demonstrates solid developing research impact, strong collaboration, and a promising trajectory in preventive cardiology and biomarker-based risk stratification.

Profile: Scopus

Featured Publications

Taş, A., Tunca, Ç., Tanık, V. O., & Özlek, B. (2025). The Scottish inflammatory prognostic score: A novel biomarker for predicting in-hospital mortality in acute heart failure with reduced ejection fraction. Heart & Lung, 74, 291–299.